Company in China’s Vaccine Scandal Violated Rules Since 2014, Xinhua Reports
- Overseas shipments of affected rabies vaccines being recalled
- Impact on overall drug sector is exaggerated: Credit Suisse
A nurse prepares a vaccination shot at the local disease control and prevention center in Jiujiang, China.
Photographer: AFP via Getty ImagesThis article is for subscribers only.
The Chinese pharmaceutical company at the center of a vaccine scandal violated rules for more than four years, and a recall of affected overseas shipments has begun.
A State Council investigation found Changsheng Bio-technology Co. infringed standards starting from as far back as April 2014 on a rabies vaccine, according to a Xinhua report posted on the government’s website. Investigators said the company used expired materials for some batches, while some production dates marked on products were false. A portion of the vaccines involved were sold abroad, and China has taken steps to recall them.